Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
18.07
-0.19 (-1.04%)
At close: Aug 27, 2025, 4:00 PM
18.10
+0.03 (0.17%)
After-hours: Aug 27, 2025, 7:59 PM EDT
Sarepta Therapeutics Market Cap
Sarepta Therapeutics has a market cap or net worth of $1.78 billion as of August 27, 2025. Its market cap has decreased by -85.14% in one year.
Market Cap
1.78B
Enterprise Value
2.34B
1-Year Change
-85.14%
Ranking
Category
Stock Price
$18.07
Market Cap Chart
Since December 1, 1998, Sarepta Therapeutics's market cap has increased from $58.40M to $1.78B, an increase of 2,940.87%. That is a compound annual growth rate of 13.61%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 26, 2025 | 1.78B | -84.64% |
Dec 31, 2024 | 11.61B | 28.75% |
Dec 29, 2023 | 9.02B | -20.70% |
Dec 30, 2022 | 11.37B | 45.06% |
Dec 31, 2021 | 7.84B | -41.72% |
Dec 31, 2020 | 13.45B | 39.87% |
Dec 31, 2019 | 9.62B | 31.90% |
Dec 31, 2018 | 7.29B | 102.79% |
Dec 29, 2017 | 3.60B | 140.16% |
Dec 30, 2016 | 1.50B | -14.27% |
Dec 31, 2015 | 1.75B | 192.17% |
Dec 31, 2014 | 597.80M | -21.92% |
Dec 31, 2013 | 765.60M | 16.58% |
Dec 31, 2012 | 656.70M | 549.55% |
Dec 30, 2011 | 101.10M | -57.54% |
Dec 31, 2010 | 238.10M | 47.70% |
Dec 31, 2009 | 161.20M | 244.44% |
Dec 31, 2008 | 46.80M | -38.26% |
Dec 31, 2007 | 75.80M | -54.99% |
Dec 29, 2006 | 168.40M | 10.50% |
Dec 30, 2005 | 152.40M | 79.51% |
Dec 31, 2004 | 84.90M | -33.15% |
Dec 31, 2003 | 127.00M | -3.93% |
Dec 31, 2002 | 132.20M | -47.73% |
Dec 31, 2001 | 252.90M | 148.18% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 638.90B |
Johnson & Johnson | 431.79B |
AbbVie | 372.04B |
UnitedHealth Group | 278.42B |
Novo Nordisk | 253.97B |
AstraZeneca | 251.25B |
Novartis AG | 246.51B |
Abbott Laboratories | 230.77B |